FDA Drug Application (050621) for SUPRAX by LEDERLE

Back to FDA Applications sponsored by LEDERLE

Application Number050621
Product Number001
FormTABLET;ORAL
Dosage200MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSUPRAX
Active IngredientCEFIXIME

Active IngredientCount
List of drugs with Active Ingredient CEFIXIME2


Back to FDA Applications sponsored by LEDERLE